{"id":201451,"date":"2026-02-24T11:10:58","date_gmt":"2026-02-24T11:10:58","guid":{"rendered":"https:\/\/quixnet.net\/wpinstance\/gilead-sciences-to-acquire-arcellx-to-maximize-long-term-potential-of-anito-cel-gilead-sciences\/"},"modified":"2026-02-24T11:10:58","modified_gmt":"2026-02-24T11:10:58","slug":"gilead-sciences-to-acquire-arcellx-to-maximize-long-term-potential-of-anito-cel-gilead-sciences","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/gilead-sciences-to-acquire-arcellx-to-maximize-long-term-potential-of-anito-cel-gilead-sciences\/","title":{"rendered":"Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel &#8211; Gilead Sciences"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiwwFBVV95cUxPdDQ5TVllWVoyejZXRmZXcEtqemt2OVNMeDc0M2NTNVFnZmctUC1hX0VwWVI4UlY4SC1PUDRTaGNCa3dyby1wWFR0VThWMk9JcmY3LWtXb2NtdkhJTjNTRzhmTzV1dGJOLWRkdTlkZThnTnZERlVIdF9mMzNneEJHaEswWjhwc3BBX2lpYTBOVlhLTjFEMEwxWXRoUmJPeWswam9pek5uR1lNU1BOYnBtV0hCeGd4Z3pIeWxRQWRKN0ZDcXc?oc=5\" target=\"_blank\">Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Gilead Sciences<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMigAFBVV95cUxNYUUyZVhTZ0NZekVxc0VlMjEwLUpPenUxcHZqRVlZczliNVV6cWpTc3M3V0E1UlQwblp6bmpIdU5TOUZjakNlZTVZYjdOV3pCaDhVVG1zeHBHcmJhRjdrTVUzRnNjXzVhcnZweHlvaG1tYzZrOUVYLUZxeXgzRmdNaw?oc=5\" target=\"_blank\">This Biotech Stock Is Having Its Best Day Ever. Gilead Sciences Is Buying It.<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barron&#8217;s<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMikwFBVV95cUxNU0dTYnliaW9YYUgzMHdNRHZHRTdSQkJBMkJrUjh0eFZRbjNscmhCWllDT3ZELW50UE5kOFoyVGNiR0I4S3h5Z3lNYU93ZU5WaURlbVFQUzNUSmt4V3F1c3VNbW11YmxELXZYQW9wcVZib19HZWMwWkNabEFOcHQtcDV2RlIxeVlFb0ZaVmZVMkhmalE?oc=5\" target=\"_blank\">Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMigwFBVV95cUxPX3BYTUtWb0xTM0UxWjVpUm5MNkNIVjhNWGxOTkMzWUZXVWhhVjN4bG91YmR6RUpnRnI0blJwcUxlTW9wSWxkWHA0S2V5Ml9pZndHMkFGQk9HQ0psS21fdlIwbkktSnNvMWdkUUxGdVhFdWNPVEJ1dlNuTjgtYVhXS2Fqaw?oc=5\" target=\"_blank\">Here&#8217;s Why Shares of Arcellx Are Up Almost 80% Today<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMipAFBVV95cUxQT0FvN2V6Q2ZNc2lBUFFDMHZObXp4VWwzM01RM3AxLXpma3JST1dXUkNCTlpHRjhEUnI1ZDBFQkNZc0hROXI5WjdOSmYtNXFKb1pNbE16NFU2eHg5eVV2Z0twVEY1b2RLd2ZIWHlXNjdQQ1Yxc1hqcEI4d3pEMnA1T1pmeWJHa2tHaU91N0ZPeHUzZ0lLcVhTd3dsRTRtdlhJQTBNZw?oc=5\" target=\"_blank\">Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">WSJ<\/font><\/li>\n<\/ol>\n<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiwwFBVV95cUxPdDQ5TVllWVoyejZXRmZXcEtqemt2OVNMeDc0M2NTNVFnZmctUC1hX0VwWVI4UlY4SC1PUDRTaGNCa3dyby1wWFR0VThWMk9JcmY3LWtXb2NtdkhJTjNTRzhmTzV1dGJOLWRkdTlkZThnTnZERlVIdF9mMzNneEJHaEswWjhwc3BBX2lpYTBOVlhLTjFEMEwxWXRoUmJPeWswam9pek5uR1lNU1BOYnBtV0hCeGd4Z3pIeWxRQWRKN0ZDcXc?oc=5\">source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel&nbsp;&nbsp;Gilead Sciences This Biotech Stock Is Having Its Best Day Ever. Gilead Sciences Is Buying It.&nbsp;&nbsp;Barron&#8217;s Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion&nbsp;&nbsp;Reuters Here&#8217;s Why Shares of Arcellx Are Up Almost 80% Today&nbsp;&nbsp;Yahoo Finance Gilead Sciences to Buy Arcellx in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":201452,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4],"tags":[],"class_list":{"0":"post-201451","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-breaking-news-video","8":"entry"},"_links":{"self":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/201451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/comments?post=201451"}],"version-history":[{"count":0,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/201451\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media\/201452"}],"wp:attachment":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media?parent=201451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/categories?post=201451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/tags?post=201451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}